EyePoint, Inc. (EYPT)
4.45
-0.05
(-1.11%)
USD |
NASDAQ |
Sep 01, 12:01
EyePoint Cash from Operations (TTM) : -267.30M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -267.30M |
| March 31, 2026 | -267.54M |
| December 31, 2025 | -240.11M |
| September 30, 2025 | -210.91M |
| June 30, 2025 | -190.59M |
| March 31, 2025 | -148.18M |
| December 31, 2024 | -126.23M |
| September 30, 2024 | -113.49M |
| June 30, 2024 | -89.66M |
| March 31, 2024 | -12.46M |
| December 31, 2023 | 1.875M |
| September 30, 2023 | 12.40M |
| June 30, 2023 | 14.46M |
| March 31, 2023 | -61.68M |
| December 31, 2022 | -65.00M |
| September 30, 2022 | -69.08M |
| June 30, 2022 | -63.74M |
| March 31, 2022 | -55.16M |
| December 31, 2021 | -50.10M |
| September 30, 2021 | -27.53M |
| June 30, 2021 | -18.61M |
| March 31, 2021 | -13.19M |
| December 31, 2020 | -14.44M |
| September 30, 2020 | -31.82M |
| June 30, 2020 | -47.72M |
| Date | Value |
|---|---|
| March 31, 2020 | -59.71M |
| December 31, 2019 | -56.70M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| June 30, 2017 | -20.49M |
| March 31, 2017 | -20.38M |
| December 31, 2016 | -20.14M |
| September 30, 2016 | -18.31M |
| June 30, 2016 | -16.32M |
| March 31, 2016 | -14.98M |
| December 31, 2015 | -14.63M |
| September 30, 2015 | 9.798M |
| June 30, 2015 | 10.30M |
| March 31, 2015 | 10.52M |
| December 31, 2014 | 12.62M |
| September 30, 2014 | -10.89M |
| June 30, 2014 | -10.67M |
| March 31, 2014 | -11.27M |
| December 31, 2013 | -11.38M |
| September 30, 2013 | -10.90M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Ocular Therapeutix, Inc. | -238.24M |
| Eli Lilly & Co. | 28.08B |
| Elanco Animal Health, Inc. | 617.00M |
| Amylyx Pharmaceuticals, Inc. | -126.58M |
| Nuvation Bio, Inc. | -120.52M |